Cargando…

Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population

OBJECTIVES: To estimate life expectancy over 25 years in HIV-positive people and to compare their life expectancy with recent estimates for the general population, by education. METHODS: Patients aged 20 years or older enrolled in the Swiss HIV Cohort Study 1988–2013 were eligible. Patients alive in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gueler, Aysel, Moser, André, Calmy, Alexandra, Günthard, Huldrych F., Bernasconi, Enos, Furrer, Hansjakob, Fux, Christoph A., Battegay, Manuel, Cavassini, Matthias, Vernazza, Pietro, Zwahlen, Marcel, Egger, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Epidemiology and Social
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302412/ https://www.ncbi.nlm.nih.gov/pubmed/27831953 http://dx.doi.org/10.1097/QAD.0000000000001335

Ejemplares similares

Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017)

Increases in Condomless Sex in the Swiss HIV Cohort Study
por: Kouyos, Roger D., et al.
Publicado: (2015)

Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis
por: Turk, Teja, et al.
Publicado: (2017)

Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2021)

Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
por: Scherrer, Alexandra U., et al.
Publicado: (2013)

Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
por: Scherrer, Alexandra U., et al.
Publicado: (2012)

A Comparison of Initial Antiretroviral Therapy in the Swiss HIV Cohort Study and the Recommendations of the International AIDS Society-USA
por: Wandeler, Gilles, et al.
Publicado: (2011)

CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART
por: Sauter, Rafael, et al.
Publicado: (2016)

Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor–Based Antiretroviral Treatment
por: Pyngottu, Ashima, et al.
Publicado: (2020)

Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland
por: Shilaih, Mohaned, et al.
Publicado: (2016)

Minor Protease Inhibitor Mutations at Baseline Do Not Increase the Risk for a Virological Failure in HIV-1 Subtype B Infected Patients
por: Scherrer, Alexandra U., et al.
Publicado: (2012)

Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus in Switzerland
por: Zeeb, Marius, et al.
Publicado: (2023)

The Individualized Genetic Barrier Predicts Treatment Response in a Large Cohort of HIV-1 Infected Patients
por: Beerenwinkel, Niko, et al.
Publicado: (2013)

Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study
por: Elzi, Luigia, et al.
Publicado: (2016)

IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients
por: Wójtowicz, Agnieszka, et al.
Publicado: (2019)

Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study
por: Young, Jim, et al.
Publicado: (2015)

Mortality from suicide among people living with HIV and the general Swiss population: 1988‐2017
por: Ruffieux, Yann, et al.
Publicado: (2019)

Adherence as a Predictor of the Development of Class-Specific Resistance Mutations: The Swiss HIV Cohort Study
por: von Wyl, Viktor, et al.
Publicado: (2013)

Sexually transmitted infections in HIV-infected people in Switzerland: cross-sectional study
por: Sprenger, Katharina, et al.
Publicado: (2014)

Hepatitis C virus transmission among human immunodeficiency virus‐infected men who have sex with men: Modeling the effect of behavioral and treatment interventions
por: Salazar‐Vizcaya, Luisa, et al.
Publicado: (2016)

Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort
por: Surial, Bernard, et al.
Publicado: (2019)

Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-Infection
por: Elzi, Luigia, et al.
Publicado: (2011)

Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV
por: Kusejko, Katharina, et al.
Publicado: (2020)

Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland
por: Thoueille, Paul, et al.
Publicado: (2022)

Calibration adjustments to address bias in mortality analyses due to informative sampling—a census-linked survey analysis in Switzerland
por: Moser, André, et al.
Publicado: (2018)

Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study
por: Roth, Jan A, et al.
Publicado: (2020)

Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID Study
por: Bouatou, Yassine, et al.
Publicado: (2018)

Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption
por: von Wyl, Viktor, et al.
Publicado: (2011)

Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 Epidemics
por: Kusejko, Katharina, et al.
Publicado: (2022)

Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL’HIV trial
por: Sculier, Delphine, et al.
Publicado: (2020)

Reasons for late presentation to HIV care in Switzerland
por: Hachfeld, Anna, et al.
Publicado: (2015)

Impact of Previous Virological Treatment Failures and Adherence on the Outcome of Antiretroviral Therapy in 2007
por: Ballif, Marie, et al.
Publicado: (2009)

CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study
por: Chammartin, Frédérique, et al.
Publicado: (2022)

Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link
por: Nguyen, Huyen, et al.
Publicado: (2021)

Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study
por: Kusejko, Katharina, et al.
Publicado: (2018)

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
por: Bihl, Florian, et al.
Publicado: (2015)

HIV Infection Disrupts the Sympatric Host–Pathogen Relationship in Human Tuberculosis
por: Fenner, Lukas, et al.
Publicado: (2013)

Assessing the drivers of syphilis among men who have sex with men in Switzerland reveals a key impact of screening frequency: A modelling study
por: Balakrishna, Suraj, et al.
Publicado: (2021)

The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study
por: Surial, Bernard, et al.
Publicado: (2021)

The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular Events
por: Wandeler, Gilles, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_insc98p6vj7kgk1075narmv7p9